How an MD-PhD Student With Hemophilia Made a Genetic Research Breakthrough

Nick Popp, an MSTP alumni, with hemophilia A helped to develop a powerful genetic technology called MAVE to map the effects of nearly all variants in disease related genes. His work has enabled the first comprehensive variant map for factor IX, dramatically improving the ability to diagnose hemophilia B and distinguish harmful mutations from harmless ones. This breakthrough has already guided real world clinical decisions, including diagnosing a premature infant whose genetic variant was previously classified as uncertain. Together, these advances highlight how large scale variant mapping can transform care for people with rare genetic conditions by replacing uncertainty with actionable insight.

Read the full article here: A Research Breakthrough for Hemophilia | Right as Rain